VARENICLINE STARTING MONTH BOX
For 1 unit (EA)
Pharmacies pay
$0.40 filed
1 × $0.3972 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$3.50 filed
1 × $3.50337 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
8.8× estimated
Medicare paid 8.8× what pharmacies pay.
Part D averages every strength and form sold under “Varenicline Tartrate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.46 estimated
$0.40 + $0.06 (15%) + $5.00 fee per fill = $5.46
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
VARENICLINE STARTING MONTH BOX is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “varenicline” and “varenicline tartrate”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as kit and its route as oral.
FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Ajanta Pharma USA Inc. and Camber Pharmaceuticals, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 14 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.40 for 1 unit (EA) (1 × $0.3972 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · NADAC explanation codes
The 14 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Ajanta Pharma USA Inc. | 1 | $0.3972 per EA filed |
| Apotex Corp | 1 | $0.3972 per EA filed |
| Ascend Laboratories, LLC | 1 | $0.3972 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.3972 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.3972 per EA filed |
| Dr. Reddys Laboratories Inc. | 1 | $0.3972 per EA filed |
| Florida Pharmaceutical Products, LLC | 1 | $0.3972 per EA filed |
| Glenmark Pharmaceuticals Inc., USA | 1 | $0.3972 per EA filed |
| Lupin Pharmaceuticals, Inc. | 1 | $0.3972 per EA filed |
| Macleods Pharmaceuticals Limited | 1 | $0.3972 per EA filed |
| Major Pharmaceuticals | 1 | $0.3972 per EA filed |
| Micro Labs Limited | 1 | $0.3972 per EA filed |
| NorthStar RxLLC | 1 | $0.3972 per EA filed |
| Par Health USA, LLC | 1 | $0.3972 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.3972 per EA filed |
All 15 NDCs, with labeler and price
- 00904-7415-16 · Major Pharmaceuticals · $0.3972 per EA · eff. 2026-09-23 filed
- 27241-0187-57 · Ajanta Pharma USA Inc. · $0.3972 per EA · eff. 2026-09-23 filed
- 31722-0690-31 · Camber Pharmaceuticals, Inc. · $0.3972 per EA · eff. 2026-09-23 filed
- 33342-0577-49 · Macleods Pharmaceuticals Limited · $0.3972 per EA · eff. 2026-09-23 filed
- 42571-0475-84 · Micro Labs Limited · $0.3972 per EA · eff. 2026-09-23 filed
- 43598-0023-53 · Dr. Reddys Laboratories Inc. · $0.3972 per EA · eff. 2026-09-23 filed
- 49884-0944-99 · Par Health USA, LLC · $0.3972 per EA · eff. 2026-09-23 filed
- 59651-0451-53 · Aurobindo Pharma Limited · $0.3972 per EA · eff. 2026-09-23 filed
- 60505-3615-04 · Apotex Corp · $0.3972 per EA · eff. 2026-09-23 filed
- 67877-0745-54 · Ascend Laboratories, LLC · $0.3972 per EA · eff. 2026-09-23 filed
- 68462-0895-04 · Glenmark Pharmaceuticals Inc., USA · $0.3972 per EA · eff. 2026-09-23 filed
- 70748-0125-11 · not listed as a package in the FDA directory · $0.3972 per EA · eff. 2026-09-23 filed
- 70748-0125-13 · Lupin Pharmaceuticals, Inc. · $0.3972 per EA · eff. 2026-09-23 filed
- 71921-0307-51 · Florida Pharmaceutical Products, LLC · $0.3972 per EA · eff. 2026-09-23 filed
- 72603-0478-01 · NorthStar RxLLC · $0.3972 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
6 other products in the NADAC file share an FDA nonproprietary name with VARENICLINE STARTING MONTH BOX.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CHANTIX 1 MG CONT MONTH BOX | $3.40803 per EA filed | We don’t know yet |
| CHANTIX 1 MG TABLET | $3.40803 per EA filed | We don’t know yet |
| CHANTIX STARTING MONTH BOX | $3.41102 per EA filed | We don’t know yet |
| TYRVAYA 0.03 MG NASAL SPRAY | $79.62813 per ML filed | $76.53781 per ML filed |
| VARENICLINE 0.5 MG TABLET | $0.31158 per EA filed | $3.50337 per EA filed |
| VARENICLINE 1 MG TABLET | $0.3161 per EA filed | $3.50337 per EA filed |
| VARENICLINE STARTING MONTH BOX this page | $0.3972 per EA filed | $3.50337 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $3.50 for 1 unit (EA), at an average of $3.50337 per EA in 2024 (2024-01-01 to 2024-12-31) for “Varenicline Tartrate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 569,550 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for VARENICLINE STARTING MONTH BOX labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Varenicline Tartrate / Varenicline Tartrate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists 14 of its 15 NDCs (it does not list the other one) as dosage form “KIT” with route “ORAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.